Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,301 to 2,320 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy. | BMC Nephrol | 2022 | 35354439 | PubTator, text mining | PubMed |
| Insight into the structure, physiological function, and role in cancer of m6A readers-YTH domain-containing proteins. | Cell Death Discov | 2022 | 35351856 | PubTator, text mining | PubMed |
| Roles of RNA Modifications in Diverse Cellular Functions. | Front Cell Dev Biol | 2022 | 35350378 | PubTator, text mining | PubMed |
| MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification. | Cell Biosci | 2022 | 35346372 | PubTator, text mining | PubMed |
| Transcriptome-wide N6-methyladenine methylation in granulosa cells of women with decreased ovarian reserve. | BMC Genomics | 2022 | 35346019 | PubTator, text mining | PubMed |
| Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma. | Technol Cancer Res Treat | 2022 | 35343834 | PubTator, text mining | PubMed |
| Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. | J Oncol | 2022 | 35342418 | PubTator, text mining | PubMed |
| m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency. | Clin Transl Med | 2022 | 35340126 | PubTator, text mining | PubMed |
| m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-κB-mediated antiapoptotic pathway. | Sci Adv | 2022 | 35333576 | PubTator, text mining | PubMed |
| Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes. | Nucleic Acids Res | 2022 | 35333330 | PubTator, text mining | PubMed |
| The molecular mechanism of METTL3 promoting the malignant progression of lung cancer. | Cancer Cell Int | 2022 | 35331234 | PubTator, text mining | PubMed |
| Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. | BMC Cancer | 2022 | 35331183 | PubTator, text mining | PubMed |
| Epitranscriptomic Reprogramming Is Required to Prevent Stress and Damage from Acetaminophen. | Genes (Basel) | 2022 | 35327975 | PubTator, text mining | PubMed |
| The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. | Biomolecules | 2022 | 35327559 | PubTator, text mining | PubMed |
| m6A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer. | Cancer Gene Ther | 2022 | 35318440 | PubTator, text mining | PubMed |
| SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner. | Mol Ther Nucleic Acids | 2022 | 35317283 | PubTator, text mining | PubMed |
| Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy. | Front Oncol | 2022 | 35311150 | PubTator, text mining | PubMed |
| Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma. | Front Oncol | 2022 | 35311131 | PubTator, text mining | PubMed |
| Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma. | Front Cell Dev Biol | 2022 | 35309945 | PubTator, text mining | PubMed |
| The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma. | Front Cell Dev Biol | 2022 | 35309918 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=116